{
  "docId": "019de075-14f9-764d-9ac8-e183992152e6",
  "docSlug": "6a6376e4d61d0db2f29d5d862e5685f7",
  "documentTitle": "argenx SE | Investor Presentation Deck | 22 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 22,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 16,
  "notes": "The slide uses a dual-section layout to separate commercial regulatory milestones from clinical trial data and initiation events.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-14f9-764d-9ac8-e183992152e6/19",
  "deckHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6",
  "deckJsonHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6.json",
  "deckAnchorHref": "/decks/019de075-14f9-764d-9ac8-e183992152e6#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.38,
        "x": 0.04,
        "y": 0.0014
      },
      "kind": "framework",
      "text": "Planned Commercial Milestones",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84a03d2e-d6b2-45a5-b09f-9ab2881005b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.38,
        "x": 0.04,
        "y": 0.61
      },
      "kind": "framework",
      "text": "Planned Clinical Milestones",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2dc26d5-e367-4864-8a97-1217d1d5440a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.53,
        "y": 0.68
      },
      "kind": "list",
      "text": "ARGX-117: ARDA MMN interim results: Mid-2023; ARGX-117: Initiate DGF POC study: 2H 2023; ARGX-119: Phase 1 study: Initiated",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d12498c8-22f8-43c5-8e6d-e516449c7068",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.05,
        "y": 0.68
      },
      "kind": "list",
      "text": "ADHERE data in CIDP: July 2023; ADDRESS data in Pemphigus: 4Q 2023; ADVANCE (SC) data in ITP: 4Q 2023; POC data in Post-COVID POTS: 4Q 2023; Initiate registrational trial in TED: 4Q 2023; Initiate POC studies in ANCA and AMR: 4Q 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffb76789-91fa-49c7-b7c9-eb46243fd755",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.92,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "list",
      "text": "VYVGART gMG Approval in China: YE 2023; VYVGART gMG Approval in Canada: 3Q 2023; VYVGART gMG Launch in France, UK, Italy: YE 2023; SC efgartigimod gMG PDUFA Date: June 20, 2023; SC efgartigimod gMG Approval in EU: 4Q 2023; SC efgartigimod gMG Approval in Japan: By 1Q 2024; VYVGART ITP Submission in Japan: Mid-2023",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "083dea4b-8d1a-463d-bc84-b1b213d0f414",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.34,
        "x": 0.33,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "* Pending decision from local regulatory authorities",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82c0b277-ab2c-4c59-8398-094b7d876496",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Positioned for a Catalyst-Rich 2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d42d5cc-5789-41fa-8a62-3eff1222e7d4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "ae70a9d5-2439-4c40-99b1-d6fef6ab6463",
      "evidence": "The slide uses horizontal bars and lists to map specific milestones against a timeline.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 19,
      "from": 11,
      "beatId": "14154d6d-3761-4292-8d0e-2a584e4be20e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "Outlining global launch progress, pipeline, and catalysts for growth.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}